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Abstract We developed a comprehensive and culturally
applicable empowerment intervention social self-value
package with an aim to assess its efficacy in order to
improve the quality of life (QoL) of HIV infected people
receiving antiretroviral treatment. Participants were ran-
domly allocated to receive either six weekly intervention
sessions or standard care. Nonlinear mixed-effects models
were performed to compare changes in empowerment
scores over time. Between September and November 2014,
1447 individuals were screened, of whom 132 were ran-
domly assigned to either the intervention or control group.
The mean scores of empowerment, social support and
quality of life increased and stigma scores were reduced in
the intervention group at 3- and 6-months. An intervention
effect on social support, stigma and QoL was significantly
increased by time and group with low and high empow-
erment. No adverse events were reported. The empower-
ment intervention was efficacious in improving QoL of
HIV infected people.
Resumen Hemos desarrollado un fortalecimiento com-
pleto y cultural applicable a la intervencio´n social del
paquete del valor propio con la intencio´n de evaluar su
eficacia para mejorar la calidad de vida de las personas
infectadas por el VIH que esta´n recibiendo ART. A los
participantes se les adjudico´ aleatoriamente la asignacio´n
de seis dosis semanales o los cuidados estandar. El resul-
tado de los efectos se presento´ para comparar los cambios
en los valores del fortalecimiento a lo largo del tiempo.
Entre septiembre y noviembre de 2014, 1447 individuos
fueron moritonizados, de los cuales 132 fueron aleatoria-
mente asignados para cada intervencio´n o grupo de control.
La media del valor del fortalecimiento, apoyo social y
calidad de vida incrementaron y los valores del estigma
fueron reducidos en la intervencio´n grupal entre 3 y 6
meses. Los efectos de una intervencio´n al apoyo social,
estigma y calidad de vida se incrementaron significativa-
mente en ese periodo y el grupo con un bajo y alto forta-
lecimiento. No hubo efectos secundarios notificados. La
intervencio´n en el fortalecimiento fue satisfactoria en la
mejora de la calidad de vida de la gente infectada por el
VIH.
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Background
Epidemiological studies have highlighted decreases in HIV
incidence and increased deaths related to HIV/AIDS [1–5].
However, the prevalence of HIV has remained extensive
and epidemic contained enormous heterogeneity [4].
Decreasing trends of epidemics and increased life expec-
tancy of people infected with HIV have been reported but
risky sexual behaviors have promoted the transmission of
HIV among general populations, and re-infections and co-
Electronic supplementary material The online version of this
article (doi:10.1007/s10461-016-1546-z) contains supplementary
material, which is available to authorized users.




1 Department of Public Health, Nobel College, Pokhara
University, Kathmandu, Nepal
2 Faculty of Medicine, Epidemiology Unit, Prince of Songkla




infections among HIV infected people [3, 6]. Disease
burdens are reported to be more common among HIV
infected populations compared to general populations,
altering their quality of life (QoL) [7–9]. The life expec-
tancy among people living with HIV after they have ini-
tiated suitable antiretroviral treatment (ART) or combined
antiretroviral treatment is reported to be similar to the
general population [10, 11].
Availability of the ART among HIV infected people is
very low and combined with psychological distress might
lead to the development of anxiety, low QoL and increased
stigma [4, 12]. The effect of ART on QoL was found to be
reasonable among HIV infected people [13–15]. Further,
their quality of life is influenced by health status, economic
factors and psychological status [16]. The mechanism of
how immunological and virological response influences
quality of life among HIV infected people has not been
comprehensively studied and therefore the effect of HIV
status on QoL is unclear. Albeit, much less has been
identified about the QoL of HIV infected people in com-
parison with other people despite considerable progress in
medical prospective [16, 17]. Moreover, the effect of
treatment on HIV might be affected by several factors
which would help to increase stigma, reduce QoL and
social support and disempowerment of HIV infected people
[18–21].
Social taboos and stigma are universal socio-cultural
barriers for HIV control and prevention [22, 23].
Empowerment and social support could be helpful assets
among HIV infected people to enhance their QoL, reduce
stigma and improve adherence to ART in resource poor
settings [24, 25]. A practical and integrated program is
needed for empowerment of HIV infected people [26, 27].
Empowerment would be best approached to reduce HIV
risk associated problems with cost effective interventions
[28–30]. However, HIV related empowerment based pro-
grams are sparse and it has been necessary to strengthen
and implement them with usual ART and other programs
with political and social transforms [26, 31–33].
Different organizations have set the goal to achieve zero
discrimination, transmission and stigma but the interven-
tions are too sparse to cover these goals [2, 34, 35]. In
addition, the ‘90-90-90’ target has been set by UNAIDS by
the year 2020 [36]. Therefore, extensive socially and cul-
turally accepted cost-effective interventions are needed
which enhance QoL and social support, and eliminate
stigma among HIV infected people in resource poor set-
tings [15, 37–40]. Unfortunately, most of the interventions
were established in developed countries and few from
developing countries. There is thus an urgent need to
develop a culturally sensitive intervention for use in
developing countries. An empowerment intervention pro-
gram we have developed, designed to improve QoL of HIV
infected people, was developed on the foundation of the
diffusion model of innovations [41], and followed different
theories to connect empowerment framework that assumed
to change behavior, self-esteem, social support, discrimi-
nation, stigma and QoL [6, 42–52]. The aim of this study
was to assess the efficacy of a social self-value empower-
ment intervention package to improve QoL of HIV infected
people receiving ART. Furthermore, we assessed the effect
of this intervention to enhance social support and reduce
stigma.
Methods
Study Design, Settings and Participants
In this open label, parallel, randomized controlled trial,
HIV infected participants receiving ART from the ART
center in Kathmandu, Nepal were recruited. The study was
carried out between September 2014 and June 2015 in
Sukraraj Tropical and Infectious Disease Hospital
(STIDH), Teku, Kathmandu, which is administered by the
National Center for AIDS and STD Control (NCASC) [53].
STIDH is the largest ART center in the country that has
been providing multidisciplinary medical services for all
HIV infected people since 2004 [54]. Details of the study
participants recruitment and design are presented in Fig. 1.
To be included in the study, participants had to be HIV
infected, aged 18 years or older, and have been receiving
ART between 6 months and 2 years prior to the study as
per the national ART guidelines of NCASC [55]. Partici-
pants with severe health problems (including psychotic
disorders, visual and hearing problems), had attended
similar intervention programs or any other education
Fig. 1 Study design and participant enrolment flow diagram
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programs, were unable to attend all the study follow up
visits, or were unwilling to disclose their HIV status among
other participants were excluded from the study.
We calculated that 132 participants (66 in each group)
would achieve 80 % power to detect 20 % mean difference
in QoL scores between the two groups with a confidence
interval of 95 %.
Randomization and Masking
Eligible participants were randomly allocated (1:1) to
receive either the intervention sessions or standard care.
Randomization was performed by a random number gen-
erator with permuted blocks of six. Allocation concealment
was done by using sequentially numbered opaque sealed
envelopes. The random number sequence was generated by
an independent data manager. Members of the research
team and participants were masked to these numbers and
the randomization process. None of the participants were
allowed to modify their assignments after randomization.
The statistician and research staff doing the baseline and
follow up assessments were masked to assignment of
participants by using a unique code system. Enrollment,
randomization and intervention sessions were conducted
between September and November 2014. First follow up
assessments were done after 3 months from baseline
(January–February, 2015) and 6 months follow-up assess-
ments were done 3 months from the first follow up (May–
June, 2015).
Intervention Procedures
Baseline information was collected after recruitment and
allocation of the participants. The intervention was deliv-
ered over six sessions held weekly at the ART center
lasting one and half hours. Sessions were conducted with a
group of 8–10 participants. All the intervention sessions
were facilitated by two national level trainers with a public
health graduate degree. A facilitator delivered the inter-
vention with participatory learning activities, buzz ses-
sions, brain storming, lecture, and discussion techniques.
Participants were encouraged and motivated to communi-
cate and discuss with different people about prevention,
treatment and disclosure of HIV issues [56, 57].
The development of the intervention contents involved
review of existing literature that followed social learning
and action theory and empowerment principles for HIV
prevention and treatment [6, 42–52]. Culturally accepted
and adopted components were developed after several
consultations with experts and pre-tested among HIV
infected people. Based on the findings from consultants and
pre-testing, a complete manual for execution of a 6 week
group intervention was developed by the research team.
The empowerment intervention mainly focused on auton-
omy and community activism, self-esteem/self-efficacy,
self-care, optimism and control over the future, family and
social relationships, power-powerlessness, management of
stress and righteous anger, stigma and discrimination
issues, legal provisions, and human and health rights.
Details of the empowerment intervention contents are
available in Additional Table 1.
Briefly, all intervention sessions were started with group
and ground rules, formal opening and closing custom,
sharing and discussion. The first session started with rap-
port building, emotions, sharing uncomfortable situations
and management of negative feelings and anger. The sec-
ond session focused on barriers and strategies of HIV
disclosure, self-esteem/self-respect/self-worth, stigma and
defeat with stigma. The third session involved discussions
about healthy body with healthy mind, healthy sexual
relations, means to be HIV infected or non-infected and to
be a man or woman, optimism and control over the future,
sexuality, adherence of ART and other treatment and pre-
vention options. The fourth session involved educated
strategies for planning healthy relations with family
members, the community and society, ways of effective
communication and maintaining healthy relations, auton-
omy and community activism, and roles and responsibili-
ties in the society. The fifth session involved education
about the effects of alcohol consumption, drug use,
smoking, developing skill to prevent co-infection, re-in-
fection and risky sexual behavior, diet and exercise. In the
sixth session, participants were educated about legal
empowerment, human rights, legal protection, powerless-
ness, discrimination, stress, freedom of voice against dis-
crimination, health rights and future goals [56].
Fidelity of the intervention was maintained with con-
tinuous monitoring of the allocated time for topic, methods
and contents of the sessions by a health officer and
supervised by the research team leader. Participants were
assured to receive equal chances on discussion with pri-
vacy. A checklist was developed to maintain fidelity of the
intervention. The checklist included intervention contents
(each session had different contents), time allocated for
each activity, participants interaction with listening,
openness, attentiveness, engagement, understanding and
reinforcement and an agenda for the next session. The
percent of items rated as ‘‘appropriate’’ by the reviewer
was more than 95 %, however we had only one reviewer
due to limited manpower in the government agency so we
could not calculate the level of agreement. A debriefing
session was conducted at the end of each session for the
feedback from the reviewer and facilitators. Intervention
sessions were not gender-separated. We measured the
acceptability using a session evaluation form (SEF) [58]
and satisfaction of the participants in the intervention using
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a client satisfaction questionnaire (CSQ-8) [59] at the end
of the intervention. All the items in the SEF indicated a
higher level acceptability among the intervention group.
The mean score of all items ranged from 3.68 to 3.82 with
a standard deviation of 0.39 to 0.47. The total score indi-
cated that participants either agreed or strongly agreed with
the sessions. The level of participant satisfaction was high.
All the participants stated that the quality of the interven-
tion was excellent. The majority of participants (92.4 %)
were very satisfied with the amount of help provided to
them. Almost all (95.5 %) agreed to join the program again
and were willing to refer it to others (data not shown).To
maintain compliance, at the end of each session the
counselors motivated participants to participate in the next
session, encouraged voluntary independent participation
and provided gift vouchers. The overall retention rate was
96.6 % in the intervention session. All the participants
were compensated for each of their six sessions with an
equivalent of USD 20.
Standard Care
All participants received routine standard care as per the
NCASC guidelines [55]. This included pre ART counsel-
ing, routine medical and laboratory tests and monthly fol-
low up for ART. Standard care in Nepal is provided by
government organizations and ART is dispensed free of
charge.
Study Procedures
Participants were asked to provide information on clinical
and behavioral characteristics, QoL, stigma, social support
and empowerment at baseline, and at the scheduled 3- and
6-months follow up visits. To minimize data entry errors
and enhance quality control, double data entry was
employed and extensively supervised by the research team
leader. Anonymity and confidentiality were maintained
with assigned unique codes at randomization, baseline and
Table 1 Clinical and
behavioral characteristics
Control group (n = 66) Intervention group (n = 66) p value
Age at HIV diagnosis
Median (IQR) 33 (26.5, 41) 33 (30, 40) 0.56
B33 years 34 (51.5) 34 (51.5) 0.10
[33 years 32 (48.5) 32 (48.8)
Age at ART initiation
Median (IQR) 35 (28, 42.8) 35 (30.2, 40.8) 0.55
B35 years 36 (54.5) 38 (57.6) 0.86
[35 years 30 (45.5) 28 (42.4)
Duration of ART 0.60
\1 year 38 (57.6) 34 (51.5)
C1 years 28 (42.4) 32 (48.5)
Spouse HIV status 0.15
Negative 16 (27.6) 26 (41.9)
Positive 42 (72.4) 36 (58.1)
Mode of HIV transmission 0.16
Others 34 (51.5) 25 (37.9)
Sex-worker 32 (48.5) 41 (62.1)
Sexual intercourse in last 3 months 1.00
Yes 50 (75.8) 50 (75.8)
No 16 (24.2) 16 (24.2)
Extra-marital sex 0.78
Yes 7 (14) 9 (18)
No 43 (86) 41 (82)
Clinical stage 1.00
I and II 34 (51.5) 35 (53)
III and IV 32 (48.5) 31 (47)
Known co-morbidities 0.80
Tuberculosis 10 (15.2) 8 (12.1)
Other 56 (84.8) 58 (87.9)
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follow up. The intervention protocol and tools were pre-
tested among ten HIV infected people before data collec-
tion. All tools were translated into Nepali and back trans-
lated into English and appeared culturally suitable to the
experts.
Outcomes
Background, behavioral and clinical characteristics of the
participants were collected including age at HIV diagnosis,
age at ART initiation, HIV status of spouse, mode of HIV
transmission, sexual intercourse in the last 3 months and
extra-marital, clinical stage, co-morbidity, adherence to
ART (coded as yes or no) and empowerment. The primary
outcome was QoL. Secondary outcomes were stigma and
social support.
QoL was measured using WHOQoL-HIV [60] which
contains 29 items divided into six domains, namely phys-
ical, psychological, level of independence, social, envi-
ronmental and spiritual. It has also one general item score
that measures overall quality of life and general health. All
the items were rated using a 5-point Likert scale where 1
indicated low or negative perceptions and 5 indicated high
or positive perceptions. Higher scores indicated better
quality of life. All the domain scores were obtained by
adding the component means in the individual domain, and
dividing by the number of components in that domain, and
multiplying by 4, so that scores ranged from 4 (worst
possible QoL) to 20 (best possible QoL).
Social support was measured using the social support
questionnaire number (SSQN) and social support ques-
tionnaire satisfaction (SSQS) scales [61]. SSQN indicates
number of supportive persons and SSQN indicates satis-
faction with available social support. Both domains inclu-
ded six questions. The SSQN collected the number of
supportive persons that denotes different types of social
support. The SSQS were rated using a 6-point Likert scale
ranging from very dissatisfied to very satisfied with avail-
able support. Higher SSQN scores indicated a perceived
higher level of supportive persons and higher SSQS scores
indicated higher level of satisfaction from available
support.
Stigma was measured using a 23-item scale question-
naire [62]. Each item was rated using a 4-point agreement
scale ranging from strongly disagree to strongly agree.
Total stigma scores ranged from 23 to 92. There were three
subscales, namely shame/blame/social isolation (10–40
score), perceived discrimination (8–32 score) and equity
(5–20 score).
Empowerment was measured using a 28-item scale
questionnaire [63] containing a 4-point agreement scale
ranging from strongly disagree to strongly agree. Total
scores ranged from 28 to 112. Empowerment was then
classified into low or high using the first quartile score as
the cut-off value to ensure the sample sizes were adequate.
Statistical Analyses
Each study group’s clinical and behavioral characteristics
measured were initially compared using Chi square tests or
Fisher’s exact test for categorical outcomes and Wil-
coxon’s signed rank test and unpaired t-tests for continuous
outcomes, as appropriate.
Nonlinear mixed-effects regression models were used to
evaluate the effect of the intervention on the primary and
secondary outcomes. Covariates included empowerment,
adherence to ART, age, sex, time (baseline, 3-, or 6-months
follow-up), and group-by-time interactions. The mixed
effect model was used to adjust for the underestimation of
variances in analysis for longitudinal data [64]. The effects
of empowerment, social support and stigma on the QoL
were also analyzed with a mixed effect model.
Nonparametric mixed-effects regression models were
also used to evaluate the relative intervention effects on
social support, stigma and QoL with and without stratifi-
cation by empowerment. Relative intervention effects with
95 % confidence intervals with and without stratification
by empowerment level among both intervention and con-
trol groups at baseline, 3- and 6-months follow up were
presented. Estimated improvements with 95 % confidence
intervals were plotted.
All statistical analyses were conducted with R software
[65]. p values less than 0.05 were considered to be
significant.
Ethical Considerations
Extensive anonymity, confidentiality and privacy were
maintained during the recruitment, intervention and data
collection process. Confidentiality and safety of the inter-
vention study data were maintained as per the standard
protocol [66]. National guidelines and principles of Nepal
health research council, and the declaration of Helsinki
were followed to obtain written informed consent and
enrollment of the participants. Participants were fully
informed about time, methods, and their right to withdraw
at any time and skip any question for any reason. Reim-
bursement for travel cost during the intervention and fol-
low up period were provided to all the participants. No
conflict of interest and no direct or indirect financial ben-
efits were anticipated by researchers in this intervention.
Research Ethics Committee, Faculty of Medicine,
Prince of Songkla University, Thailand (57-0146-18-5) and
Institutional Ethical Review Committee of STIDH, Nepal
(063/071/72) approved this study. The trial was registered
AIDS Behav
123
through Thai Clinical Trial Registry with registration
number TCTR20140814002 (www.clinicaltrials.in.th).
Results
A total of 1447 HIV infected people receiving ART were
screened from September to November 2014, of which
1135 were ineligible due to age \18 years (n = 75),
duration of ART\6 months or[24 months (n = 1050),
and others (n = 10). 180 eligible participants refused to
join the study, giving a response rate of 42.3 %. Finally,
132 participants were recruited and randomly assigned to
the control group (n = 66) or intervention group
(n = 66).The diagram of participant flow is presented in
Fig. 1. All the recruited participants completed the study at
baseline, 3- and 6-months follow up. The overall retention
rate was 96.6 %. No unfavorable events were reported
during the study period.
The mean age of the participants was 36.1 (SD = 7.8)
years. Most of the participants were female (53 %), non-
indigenous (56.1 %), could read and write only (28.8 %),
and were married (74.2 %). The majority (84.8 %) of
participants had an average of two children and there were
no significant differences at baseline between the control
and intervention groups. Table 1 compares baseline
behavioral and clinical characteristics between participants
in the two groups. More than 50 % of participants were
diagnosed with HIV before 33 years of age among both
control and intervention groups. Two thirds of participants
(62.1 %) in the intervention group were infected through
sexual contact. Three fourths (75.8 %) were sexually active
within the last 3 months. No significant differences of
behavioral and clinical characteristics were detected
between the two groups.
The mean empowerment, social support, stigma and
QoL scores are presented in Table 2. All the scores at
baseline were equally static in both groups. The mean
scores of empowerment and QoL increased two-fold in the
intervention group at 3 months but no further increase at
6 months. Stigma scores were reduced by half at 3 months
in the intervention group with no further changes at
6 months. Social support scores increased by 1.5 times
higher at 3 months follow up in the intervention group
compared to the control group. Overall mean QoL scores at
3 months increased by 80 % in the intervention group. The
relative intervention effects among total social support with
number (TSSQN), total social satisfaction with support
(TSSQS), stigma and QoL had a similar trend in the
intervention group (Fig. 2). Minimal improvements of
outcomes were observed in the control group. Figure 3
reveals the relative intervention effects of social support,
stigma and QoL by level of empowerment. The effects of
the intervention on social support, stigma and QoL per-
sisted at 6 months regardless of level of empowerment
(high vs. low).
Table 3 presents the outcomes from the nonlinear
mixed-effects regression model. Empowerment
Table 2 Mean values of empowerment, stigma, social support and quality of life scores among HIV infected people
Baseline 3 months follow up 6 months follow up
Control Intervention Control Intervention Control Intervention
Empowerment 46.70 46.38 48.23 94.68 46.53 95.92
Social support
TSSQN 15.04 14.70 16.92 28.09 18.58 30.70
TSSQS 15.04 15.42 17.44 29.00 19.44 32.67
Overall stigma 76.03 76.50 72.91 39.41 73.03 38.26
Shame/blame/social isolation 33.11 33.64 32.21 16.89 31.27 16.76
Perceived discrimination 26.00 26.17 24.36 14.45 24.95 13.86
Equity 16.92 16.70 16.33 8.06 16.80 7.64
Overall quality of life 7.76 7.68 8.46 15.47 8.15 15.81
Physical 8.06 7.89 8.59 15.74 8.23 15.88
Psychological 7.78 7.76 8.10 16.04 8.05 15.99
Independence 7.42 7.32 8.58 15.51 8.32 15.65
Social relations 7.61 7.53 8.74 15.47 8.17 15.82
Environment 7.48 7.48 8.20 15.14 7.98 15.68
Spiritual/religious/personal belief 8.45 8.27 8.88 15.12 8.39 15.92
General overall health 11.97 11.58 10.64 13.76 9.88 15.03
TSSQN total social support with number, TSSQS total satisfaction with social support
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significantly reduced stigma and increased QoL (p\ 0.001
and p\ 0.001) after adjusting for age, gender, adherence
to ART, group and time. There was no significant differ-
ence in any outcome between the intervention and control
group at baseline. There were significant interaction effects
of intervention by time indicating that improvements in
social support and QoL for the intervention group were
significantly higher compared to the control group over
time (p\ 0.001), while stigma was significantly lower
(p\ 0.001). Estimated differences in improvement in
social support, stigma and QoL at 3- and 6-months from
baseline between intervention and control were significant
(all p values\ 0.001). Increasing ART adherence was
associated with a reduction of stigma (p\ 0.001). Age and
gender were not significantly associated with any outcome.
Predictors of overall QoL are presented in Table 4.
Increased empowerment had a significantly higher level of
QoL (p\ 0.001). Increased stigma had a lower level of
QoL but this was not statistically significant. Social support
had no significant effect on QoL. Improvement in QoL
remained statistically significant at 3- and 6-months follow
up (p\ 0.001).
Discussion
Empowerment, social support, stigma and QoL of HIV
infected people at baseline were low among both groups.
The improvement of social support, stigma and QoL was
seen immediately after 3 months among those in the
intervention group and persisted for another 3 months. The
intervention positively affected social support, stigma and
QoL in the equivalence regardless of level of baseline
empowerment. Empowerment significantly affected social
support, stigma and QoL but only empowerment was
shown to be a significant predictor of QoL in addition to
the intervention.
Fig. 2 Relative intervention effects on social support, stigma and
quality of life using nonlinear mixed-effect model. All p values for
time trend between intervention and control on each outcome were
significantly different with p\ 0.001, 3mo three months follow up,
6mo six months follow
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Clinical and behavioral characteristics were not signifi-
cantly different at baseline between the two groups.
Recruitment process followed strong protocol that assured
the high retention rate in the intervention and lower loss to
follow up. Most eligible participants declined to participate
in the study; however, there was no difference in their
background characteristics compared to those who partic-
ipated in the study. Reasons for refusal to participate in the
study were: too busy, unable to manage time for all the
intervention sessions, lack of interest in the study and
unavailability for follow up.
Social support was significantly improved by enhancing
empowerment in the intervention group. As far as in our
knowledge, empowerment interventions for all the HIV
infected population were not available and comparison of
the results with this trial would be difficult. A randomized
controlled trial using a group support psychotherapy for
HIV infected people as an intervention and measured at the
same period as our study also showed an increasing social
support after intervention by time [67]. Slightly improved
social support in the control group at 3 months might be
explained by learning process of participants from the
repetitive questionnaires inducing their behavior changes
(pretest sensitization effect) and possible effects of the
contamination [68]. Stigmatization, discrimination, and
cognitive state—the psychological condition that is char-
acterized by a lack of obvious and logical belief and
behavior—might be removed with increased social support
through empowerment.
Overall stigma decreased after the intervention, more so
in the intervention group. This finding was supported by
the conclusion of systematic reviews that focused on any
Fig. 3 Relative intervention effects on social support, stigma and
QoL stratified by empowerment using nonlinear mixed-effect model.
All p values for time trend between intervention and control on each
outcome were significantly different with p\ 0.001, 3mo three
months follow up, 6mo six months follow up
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interventions for stigma reduction [69, 70]. Further, it has
been suggested that the limited interventions were avail-
able to combat different forms of stigma and discrimination
experienced by HIV infected people [70]. Therefore, our
study applied an empowerment strategy to overcome and
resist the manifestation of discrimination and stigma
among HIV infected people with the adaptation of local
context and culture. In addition, empowerment would help
to defeat symptoms of stigma among HIV infected people
and our trial found that increased empowerment could
significantly reduce stigma. This result was similar to a
systematic review and meta-synthesis which highlighted
increased adherence were linked with decreased stigma
[71].
The intervention was found to be significantly effective
for improving QoL. Systematic reviews based on different
interventions and observational studies which focused on
QoL of HIV infected populations showed inconclusive
results [72–75]. This might be due to the use of different
measurement scales, sampling process and sample size,
culture and context of study settings in different studies.
Therefore, we used different analytical approaches and
pretested cultural and contextual appropriateness of the
intervention manual which could improve the reliability of
the outcome.
Existing cross-sectional studies from China suggested
that social support and stigma were correlated with QoL
and social support was the moderator of the impact of
stigma on QoL of HIV infected people [76, 77]. A sys-
tematic review revealed that social support and ART
adherence were associated with QoL of HIV infected
people [78]. However, in this study, social support, stigma
and ART adherence were not statistically significant but
increased stigma showed negative effects on QoL. The
Table 3 Effect of empowerment intervention on social support, stigma and quality of life using nonlinear mixed-effects regression model
Parameter TSSQN TSSQS Stigma Quality of life
Estimate SE p value Estimate SE p value Estimate SE p value Estimate SE p value
Empowerment -0.010 0.038 0.795 -0.024 0.040 0.544 -0.127 0.038 \0.001 0.057 0.009 \0.001
Age -0.001 0.028 0.997 -0.038 0.029 0.196 0.005 0.016 0.744 0.005 0.005 0.289
Male versus female 1.196 0.449 0.008 1.215 0.464 0.009 0.315 0.250 0.208 -0.009 0.074 0.896
ART adherence -0.681 0.393 0.083 -0.424 0.409 0.300 -1.300 0.402 \0.001 0.145 0.105 0.151
Intervention versus control
at baseline
-0.496 0.532 0.351 0.243 0.550 0.659 0.388 0.425 0.360 -0.060 0.109 0.579
Time (months) \0.001 \0.001 \0.001 \0.001
Intervention 9 Time \0.001 \0.001 \0.001 \0.001
Difference in improvement from baseline between intervention and control group
3 months follow up 11.983 1.868 \0.001 12.304 1.936 \0.001 -28.028 1.890 \0.001 4.430 0.474 \0.001
6 months follow up 12.967 1.977 \0.001 14.041 2.049 \0.001 -28.927 1.998 \0.001 4.904 0.501 \0.001
SE standard error, TSSQN total social support with number, TSSQS total satisfaction with social support
Table 4 Prediction of QoL by
intervention group after
adjusting for level of
empowerment, social support
and stigma using nonlinear
mixed-effects regression model
Parameter Quality of life
Estimate SE p value
Empowerment 0.057 0.009 \0.001
TSSQN 0.007 0.012 0.574
TSSQS -0.009 0.011 0.410
Stigma -0.004 0.012 0.771
Intervention effect at baseline (intervention vs. control) -0.051 0.108 0.371
Time (in months) \0.001
Intervention 9 time \0.001
Estimated difference in improvement in QoL from baseline (intervention vs. control)
3 months follow up 4.310 0.610 \0.001




small sample size could be the possible reason that we
could not established statistically significant results with
these variables.
This study has several strengths. First, this randomized
controlled trial was based on real world study settings that
represent the ART receiving HIV infected individuals.
Second, the intervention attendance and retention rate was
high which signifies the feasibility and acceptability of the
intervention for HIV infected people. Third, this is the first
multidimensional outcome related trial in Nepal for HIV
infected people. Fourth, the intervention process followed
extensive quality control and results on all study effects
were large. We followed rigorous analysis methods and
reported the effect sizes of all the outcomes. Lastly, ran-
domization process, pretested tools, intervention manual
and blinding analysis assessor increased the validity and
reliability.
This study has several limitations. First, we delivered
the intervention in a single study setting and participants
were not blinded, which could lead to contamination.
However, we detected highly significant differences among
the intervention and control group at 3- and 6-months after
baseline. Second, the intervention was delivered by skilled
personnel with public health graduate degrees, thus limited
availability of skilled personnel would limit its sustain-
ability and accessibility. Next, the intervention was led by
less trained service providers need to be assessed. Third,
we did not assess and determine if the benefit of the
intervention was sustainable; we only assessed the outcome
at 3- and 6-months follow up. Fourth, outcomes of sub-
group analyses were difficult to validate due to the small
sample size. Finally, we did not cover the economic and
biomarker aspects.
Conclusions
Rigorously designed intervention indicates that empower-
ment intervention can increase QoL of HIV infected peo-
ple. Further, it could be useful to reduce stigma and
increase their social support network. Findings could be
utilized at regular service settings for its sustainability and
long-term effect. Although the intervention effects on
secondary outcomes were detected, we recommend eval-
uating in future multicenter studies with large sample sizes
for monitoring the long term effects.
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